PoliticsAdvisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug 6 months ago01 mins The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously. Post navigation Previous: Law Enforcement Unit Formed to Crack Down on Illegal E-CigarettesNext: Ukraine Reconstruction Official Resigns, Highlighting Tensions Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
